This brand name is authorized in Nigeria.
The drug ANUDOL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
SOI2LOH54Z - ZINC OXIDE
|
Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells. |
|
2
|
UNII
YIW503MI7V - BISMUTH SUBGALLATE
|
3
|
Balsam Peru
UNII
8P5F881OCY - BALSAM PERU
|
4
|
Bismuth oxide
UNII
A6I4E79QF1 - BISMUTH OXIDE
|
5
|
Hard fat
UNII
8334LX7S21 - HARD FAT
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
C05AX02 | Bismuth preparations, combinations | C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A11-100196 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.